Found: 44
Select item for more details and to access through your institution.
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 10, p. 1, doi. 10.1007/s00432-024-05945-6
- By:
- Publication type:
- Article
Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 7, p. 1182, doi. 10.3390/jpm13071182
- By:
- Publication type:
- Article
The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1178, doi. 10.1111/bjh.19273
- By:
- Publication type:
- Article
Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 48, doi. 10.1111/bjh.18738
- By:
- Publication type:
- Article
Management of secondary central nervous system lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 160, doi. 10.1111/bjh.18539
- By:
- Publication type:
- Article
Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 4, p. 507, doi. 10.1111/bjh.18396
- By:
- Publication type:
- Article
Population‐based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large‐cell lymphoma using Public Health England data.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 932, doi. 10.1111/bjh.17896
- By:
- Publication type:
- Article
Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 507, doi. 10.1111/bjh.17951
- By:
- Publication type:
- Article
Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 4, p. 561, doi. 10.1111/bjh.17747
- By:
- Publication type:
- Article
Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 727, doi. 10.1111/bjh.17421
- By:
- Publication type:
- Article
The prevention of central nervous system relapse in diffuse large B‐cell lymphoma: a British Society for Haematology good practice paper.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 5, p. 708, doi. 10.1111/bjh.16866
- By:
- Publication type:
- Article
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 879, doi. 10.1111/bjh.16451
- By:
- Publication type:
- Article
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. 918, doi. 10.1111/bjh.16271
- By:
- Publication type:
- Article
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. 185, doi. 10.1111/bjh.16070
- By:
- Publication type:
- Article
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. e94, doi. 10.1111/bjh.15927
- By:
- Publication type:
- Article
Kinetics of T‐cell subset reconstitution following treatment with bendamustine and rituximab for low‐grade lymphoproliferative disease: a population‐based analysis.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 6, p. 957, doi. 10.1111/bjh.15722
- By:
- Publication type:
- Article
Idelalisib‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 667, doi. 10.1111/bjh.15151
- By:
- Publication type:
- Article
Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 3, p. 348, doi. 10.1111/bjh.15661
- By:
- Publication type:
- Article
Guideline for the treatment of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 344, doi. 10.1111/bjh.15460
- By:
- Publication type:
- Article
The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 3, p. 476, doi. 10.1111/bjh.14130
- By:
- Publication type:
- Article
Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 3, p. 486, doi. 10.1111/bjh.14066
- By:
- Publication type:
- Article
Does end-of-treatment FDG- PET provide any additional prognostic value to the pre-treatment NCCN- IPI score? Reply to Adams and Kwee.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 320, doi. 10.1111/bjh.14050
- By:
- Publication type:
- Article
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 1, p. 43, doi. 10.1111/bjh.14177
- By:
- Publication type:
- Article
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 2, p. 246, doi. 10.1111/bjh.13831
- By:
- Publication type:
- Article
Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 326, doi. 10.1111/bjh.12941
- By:
- Publication type:
- Article
Interpretation of retrospective data evaluating high‐dose methotrexate as central nervous system prophylaxis in diffuse large B‐cell lymphoma; caution required.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E338, doi. 10.1002/ajh.26257
- By:
- Publication type:
- Article
Epstein–Barr Virus and Infectious Mononucleosis: What Students Can Teach Us.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac046
- By:
- Publication type:
- Article
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 4, p. 559, doi. 10.1093/bjd/ljad430
- By:
- Publication type:
- Article
Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02489
- By:
- Publication type:
- Article
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1056, doi. 10.1093/neuonc/noab020
- By:
- Publication type:
- Article
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231173489
- By:
- Publication type:
- Article
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.
- Published in:
- Rheumatology, 2022, v. 61, n. 7, p. 2783, doi. 10.1093/rheumatology/keab790
- By:
- Publication type:
- Article
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S376, doi. 10.1016/S2152-2650(21)01860-7
- By:
- Publication type:
- Article
Poster: ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01533-0
- By:
- Publication type:
- Article
Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extended follow‐up of CD4<sup>+</sup> T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 137, doi. 10.1002/hon.2797
- By:
- Publication type:
- Article
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00268-z
- By:
- Publication type:
- Article
Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01144-9
- By:
- Publication type:
- Article
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 3789, doi. 10.1007/s12325-021-01764-0
- By:
- Publication type:
- Article
Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England.
- Published in:
- EJHaem, 2024, v. 5, n. 5, p. 992, doi. 10.1002/jha2.970
- By:
- Publication type:
- Article
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK.
- Published in:
- Health Science Reports, 2024, v. 7, n. 1, p. 1, doi. 10.1002/hsr2.1749
- By:
- Publication type:
- Article